This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Trip.com (TCOM), ADMA Biologics (ADMA), Lantheus (LNTH) and Skyward (SKWD) are well-poised to gain.
Will Skyward (SKWD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You Looking for a Top Momentum Pick? Why Skyward Specialty Insurance (SKWD) is a Great Choice
by Zacks Equity Research
Does Skyward Specialty Insurance (SKWD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Lincoln National (LNC) Unveils PEPs to Ease Retirement Planning
by Zacks Equity Research
Lincoln National (LNC) launches FlexPEP(k) and FlexPEP(b) to offload the plan sponsorship burden from small-to-medium businesses and not-for-profits, and offer enhanced retirement outcomes to their employees.
Key Highlights From CNO Financial's (CNO) Optavise Report
by Zacks Equity Research
CNO Financial's (CNO) Annual Benefits Broker Survey highlights the growing requirements of broker partners to address employers' regulatory and compliance management concerns.
Skyward Specialty Insurance Group, Inc. (SKWD) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Compelling Reasons to Hold on to Allstate (ALL) Stock Now
by Zacks Equity Research
Allstate (ALL) remains well-poised for growth on the back of continued rate hikes, strong investment results, divestitures and adequate cash reserves.
Best Momentum Stocks to Buy for March 14th
by Zacks Equity Research
SKWD, NVR and IMXI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 14, 2024.
New Strong Buy Stocks for March 14th
by Zacks Equity Research
IMMR, NVR, SKWD, DVA and APAM have been added to the Zacks Rank #1 (Strong Buy) List on March 14, 2024.
Best Value Stocks to Buy for March 14th
by Zacks Equity Research
IMXI, SKWD and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 14, 2024.
Skyward Specialty Insurance (SKWD) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Skyward Specialty Insurance (SKWD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Skyward (SKWD) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Skyward (SKWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stock to Buy for February 23rd
by Zacks Equity Research
AROC, CENT and SKWD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 23, 2024.
Skyward Specialty Insurance Group, Inc. (SKWD) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Skyward (SKWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Skyward (SKWD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Skyward (SKWD) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Mercury General (MCY) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Mercury General (MCY) delivered earnings and revenue surprises of 2,200% and 4.48%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CNA Financial (CNA) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CNA Financial (CNA) delivered earnings and revenue surprises of 27.88% and 5.07%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
How Are Rate Hikes Aiding Allstate (ALL) to Fight Inflation?
by Zacks Equity Research
Allstate (ALL) implements auto rate hikes in December to combat inflationary headwinds.
New Strong Buy Stocks for January 17th
by Zacks Equity Research
SKWD, PHG, BK, PAGS and GMAB have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2024.
W.R. Berkley (WRB) Gains 21% in 6 Months: More Room to Run?
by Zacks Equity Research
W.R. Berkley (WRB) stock soars on the back of high retention, growth in exposure and effective capital deployment.
3 Growth Stocks to Pick From the Top-Ranked P&C Insurance Space
by Tanuka De
Given the prospects of the Property and Casualty Insurance industry, CINF, KNSL and SKWD have the potential to generate better returns that other players.
Zacks Investment Ideas feature highlights: Instacart, Arm Holdings, CAVA Group and Skyward Specialty Insurance Group
by Zacks Equity Research
Instacart, Arm Holdings, CAVA Group and Skyward Specialty Insurance Group are part of the Zacks Investment Ideas article.
Time to Buy these Recent IPOs after Instacart's (CART) Day View?
by Shaun Pruitt
Investors may be wondering where the opportunity lies at among recent IPOs as analyst and research firms work to complete their financial estimates for Instacart (CART) and Arm Holdings (ARM).